250 related articles for article (PubMed ID: 2669913)
1. Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
Waeber B; Juillerat-Jeanneret L; Aubert JF; Schapira M; Nussberger J; Brunner HR
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):175S-180S. PubMed ID: 2669913
[TBL] [Abstract][Full Text] [Related]
2. Kinin-related effects of angiotensin-converting enzyme inhibition.
Bönner G
Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
[TBL] [Abstract][Full Text] [Related]
3. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
4. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
Kramer HJ; Glänzer K; Meyer-Lehnert H; Mohaupt M; Predel HG
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S91-8. PubMed ID: 1697369
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.
Campbell DJ
Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):903-11. PubMed ID: 8846511
[TBL] [Abstract][Full Text] [Related]
6. Does kinin mediate the hypotensive action of angiotensin converting enzyme (ACE) inhibitors?
Sharma JN
Gen Pharmacol; 1990; 21(4):451-7. PubMed ID: 2199299
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
Shimamoto K; Matsuki T; Iimura O
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
9. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
10. The brain kallikrein-kinin system. A possible role in blood pressure regulation.
Scicli AG; Carretero OA
Hypertension; 1990 Apr; 15(4):413-4. PubMed ID: 2180819
[No Abstract] [Full Text] [Related]
11. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
Bönner G
Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
[TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
Schrör K
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
[TBL] [Abstract][Full Text] [Related]
13. The kinin system: suggestions to broaden some prevailing concepts.
Erdös EG; Deddish PA
Int Immunopharmacol; 2002 Dec; 2(13-14):1741-6. PubMed ID: 12489787
[TBL] [Abstract][Full Text] [Related]
14. The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors.
Bönner G
Drugs; 1997; 54 Suppl 5():23-30. PubMed ID: 9429842
[TBL] [Abstract][Full Text] [Related]
15. Possible effects of the kallikrein-kinin system on male reproductive functions.
Schill WB; Miska W
Andrologia; 1992; 24(2):69-75. PubMed ID: 1318646
[TBL] [Abstract][Full Text] [Related]
16. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
18. [The kallikrein-kinin system and blood pressure regulation].
Yasujima M; Abe K
Nihon Rinsho; 1989 Sep; 47(9):1956-62. PubMed ID: 2593269
[No Abstract] [Full Text] [Related]
19. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
Tanaka S; Shimamoto K; Ando T; Nakahashi Y; Ura N; Hosoda S; Ishida H; Yamaji I; Yokoyama T; Masuda A
Clin Exp Hypertens A; 1987; 9(2-3):605-9. PubMed ID: 3038424
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
